Samsung Biologics Reaches Agreement With Biogen to Acquire Full Ownership of Samsung Bioepis
Agreement with Biogen to buyout Biogen’s (50% -1 share) stake in Samsung Bioepis Joint Venture for up to USDÂ $2.3 billion Transaction projected to be accretive...